Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Scios, Inc.
🇺🇸
United States
Country
🇺🇸
United States
Ownership
Subsidiary
Established
1981-01-01
Employees
509
Market Cap
-
Website
Clinical Trials
Related News
Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma
Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
Drug: SCIO-469
Drug: SCIO-469 and bortezomib
Subscribe
First Posted Date
2004-07-19
Last Posted Date
2010-10-18
Lead Sponsor
Scios, Inc.
Target Recruit Count
62
Registration Number
NCT00087867
Subscribe
Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate
Phase 2
Completed
Conditions
Rheumatoid Arthritis
Subscribe
First Posted Date
2002-08-14
Last Posted Date
2010-04-27
Lead Sponsor
Scios, Inc.
Target Recruit Count
120
Registration Number
NCT00043732
Subscribe
Prev
1
2
3
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy